Histology-based expression profiling yields novel prognostic markers in human glioblastoma

Journal of Neuropathology and Experimental Neurology

Volumn 64, Issue 11, 2005, Pages 948-955

  Dong, Shumin ^a   Nutt, Catherine L ^a   Betensky, Rebecca A ^b   Stemmer Rachamimov, Anat O ^a   Denko, Nicholas C ^c   Ligon, Keith L ^d   Rowitch, David H ^d   Louis, David N ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Glioblastoma; Glioma; Hypoxia; Necrosis; Prognosis

Indexed keywords

ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STANDARDIZATION; VALIDATION PROCESS;

EID: 27944500725     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jnen.0000186940.14779.90     Document Type: Article

References (45)

1. Jaffe ES, Harris NL, Stein H, et al. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: WHO/IARC, 2001
2. Fletcher CDM, Unni KK, Mertens F. World Health Organization Classification of Tumours of Soft Tissue and Bone. Lyon: WHO/IARC, 2002
3. Louis DN, Holland EC, Cairncross JG. Glioma classification: S molecular reappraisal. Am J Pathol 2001;159:779-86
4. Nutt CL, Mani DR, Betensky RA, et al. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res 2003;63:1602-7
5. Sasaki H, Zlatescu MC, Betensky RA, et al. Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade 'oligodendroglioma.' J Neuropathol Exp Neurol 2002;61:58-63
6. McDonald JM, See S, Tremont I, et al. Prognostic impact of histology and 1p status in anaplastic oligodendroglioma. Cancer 2005;104:1468-77
7. Ma XJ, Salunga R, Tuggle JT, et al. Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci U S A 2003;100:5974-79
8. Louis DN, Posner JB, Jacobs T, et al. Report of the Brain Tumor Progress Review Group. Bethesda, MD: National Institutes of Health, 2000
9. Burger PC, Green SB. Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer 1987;59:1617-25
10. Burton EC, Lamborn KR, Feuerstein BG, et al. Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma. Cancer Res 2002;62:6205-10
11. Kleihues P, Burger PC, Collins VP, et al. Pathology and Genetics of Tumors of the Nervous System. Lyon: WHO/IARC, 2000
12. Brat DJ, Van Meir EG. Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma. Lab Invest 2004;84:397-405
13. Brat DJ, Castellano-Sanchez AA, Hunter SB, et al. Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population. Cancer Res 2004;64:920-27
14. Graeber TG, Osmanian C, Jacks T, et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 1996;379:88-91
15. Westfall PH, Young SS. Resampling-Based Multiple Testing: Examples and Methods for P-value Adjustment. New York: John Wiley & Sons, 1993
16. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J Royal Stat Soc Series B (Methodological) 1995;57:289-300
17. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 2003;100:9440-45
18. Hsieh FY, Lavori PW. Sample-size calculations for the Cox proportional hazards regression model with nonbinary covariates. Control Clin Trials 2000;21:552-60
19. Lal A, Peters H, St. Croix B, et al. Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst 2001;93:1337-43
20. Denko NC, Fontana LA, Hudson KM, et al. Investigating hypoxic tumor physiology through gene expression patterns. Oncogene 2003;22:5907-14
21. Schmaltz C, Hardenbergh PH, Wells A, et al. Regulation of proliferation-survival decisions during tumor cell hypoxia. Mol Cell Biol 1998;18:2845-54
22. Shweiki D, Itin A, Soffer D, et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992;359:843-45
23. Kunz MI, Ibrahim SM. Molecular responses to hypoxia in tumor cells. Mol Cancer 2003;2:23
24. Salnikow K, Costa M, Figg WD, et al. Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer. Cancer Res 2000;60:5630-34
25. Kress S, Stein A, Maurer P, et al. Expression of hypoxia-inducible genes in tumor cells. J Cancer Res Clin Oncol 1998;124:315-20
26. Zhong H, Simons JW. Direct comparison of GAPDH, beta-actin, cyclophilin, and 28S rRNA as internal standards for quantifying RNA levels under hypoxia. Biochem Biophys Res Commun 1999;259:523-26
27. Shinohara Y, Hino M, Ishida T, et al. Growth condition-dependent synchronized changes in transcript levels of type II hexokinase and type 1 glucose transporter in tumor cells. Biochim Biophys Acta 2001;1499:242-48
28. Vannucci SJ, Seaman LB, Vannucci RC. Effects of hypoxia-ischemia on GLUT1 and GLUT3 glucose transporters in immature rat brain. J Cereb Blood Flow Metab 1996;16:77-81
29. Akakura N, Kobayashi M, Horiuchi I, et al. Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation. Cancer Res 2001;61:6548-54
30. Hofbauer KH, Gess B, Lohaus C, et al. Oxygen tension regulates the expression of a group of procollagen hydroxylases. Eur J Biochem 2003;270:4515-22
31. Louis DN. A molecular genetic model of astrocytoma histopathology. Brain Pathol 1997;7:755-64
32. Chiesa-Vottero AG, Rybicki LA, Prayson RA. Comparison of proliferation indices in glioblastoma multiforme by whole tissue section vs tissue microarray. Am J Clin Pathol 2003;120:902-8
33. Ohgaki HD, Jourde P, Horstmann B, et al. Genetic pathways to glioblastoma: A population-based study. Cancer Res 2004;64:6892-99
34. Okada Y, Hurwitz EE, Esposito JM, et al. Selection pressures of TP53 mutation and microenvironmental location influence epidermal growth factor receptor gene amplification in human glioblastomas. Cancer Res 2003;63:413-16
35. Blouw B, Song H, Tihan T, et al. The hypoxic response of tumors is dependent on their microenvironment. Cancer Cell 2003;4:133-46
36. Brat DJ, Kaur B, Van Meir EG. Genetic modulation of hypoxia induced gene expression and angiogenesis: Relevance to brain tumors. Front Biosci 2003;8:100-16
37. Bottaro DP, Liotta LA. Cancer: Out of air is not out of action. Nature 2003;423:593-95
38. Raza SM, Lang FF, Aggarwal BB, et al. Necrosis and glioblastoma: A friend or a foe? A review and a hypothesis. Neurosurgery 2002;51:2-12; discussion 12-13
39. Raza SM, Fuller GN, Rhee CH, et al. Identification of necrosis-associated genes in glioblastoma by cDNA microarray analysis. Clin Cancer Res 2004;10:212-21
40. Martinez-Duncker I, Mollicone R, Candelier JJ, et al. A new superfamily of protein-O-fucosyltransferases, alpha2-fucosyltransferases, and alpha6-fucosyltransferases: Phylogeny and identification of conserved peptide motifs. Glycobiology 2003;13:1C-5C
41. Shi S, Stanley P. Protein O-fucosyltransferase 1 is an essential component of Notch signaling pathways. Proc Natl Acad Sci U S A 2003;100:5234-39
42. Fadok VA, Bratton DL, Rose DM, et al. A receptor for phosphatidylserine- specific clearance of apoptotic cells. Nature 2000;405:85-90
43. van der Slot AJ, Zuurmond AM, Bardoel AF, et al. Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis. J Biol Chem 2003;278:40967-72
44. Chang HYS, Alizadeh JB, Sood AA, et al. Gene expression signature of fibroblast serum response predicts human cancer progression: Similarities between tumors and wounds. PLoS Biol 2004;2:206-14
45. Angelastro JM, Ignatova TN, Kukekov VG, et al. Regulated expression of ATF5 is required for the progression of neural progenitor cells to neurons. J Neurosci 2003;23:4590-60